A $12 Billion Takeover Says That Gene Therapy Cancer Cures Are Big BusinessMIT Technology ReviewPharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for trea… Continue reading
Genetic Engineering & Biotechnology News |
When Two Immunotherapy Rights Make a Wrong
Genetic Engineering & Biotechnology News Recent advances in immunotherapy have given many cancer patients stricken with tumors intractable to current therapies hope for meaningful remission times. While researchers continue to try and understand the intricacies of the immune system’s response … |
UCalgary News |
Researchers discover new immunotherapy combination effective at …
UCalgary News “We’ve been looking at these cancer drugs the wrong way — as tumour-targeting drugs — instead of what we now feel is their most important biological role: as … |
Medical Xpress |
Gene therapy using ‘junk DNA’ could lower risk for heart disease
Medical Xpress Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce … Familial Hypercholesterolemia: “Junk” RNA May Facilitate Gene …MedicalResearch.com (blog) |
|
FDA Raids One Stem Cell Lab and Warns Another in Regulatory Push
Bloomberg On Monday, the Food and Drug Administration released a warning letter it sent last week to Florida-based U.S. Stem Cell Inc. for selling unapproved stem–cell treatments and injecting them into patients’ spinal cords. And it raided a San Diego-based … |